Also, update research has highlighted that EZH2-mediated H3K27m3 blockade of cyclin-dependent kinase inhibitor 1C could suppress glycolysis, proliferation and migration of pancreatic cancer cells [43]. Here, CDKN1C is linked to pancreatic neoplasm.